Jane Street Group, LLC Paratek Pharmaceuticals, Inc. Transaction History

Jane Street Group, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.52 - $2.8 $37,772 - $69,580	-24,850 Reduced 62.88%	14,668 $32,000
Q1 2023 May 15, 2023	BUY	$1.37 - $2.54 $31,007 - $57,487	22,633 Added 134.04%	39,518 $100,000
Q4 2022 Feb 14, 2023	BUY	$1.67 - $2.51 $4,784 - $7,191	2,865 Added 20.44%	16,885 $31,000
Q3 2022 Nov 14, 2022	BUY	$1.96 - $2.93 $27,479 - $41,078	14,020 New	14,020 $36,000
Q4 2021 Feb 15, 2022	SELL	$4.07 - $5.3 $99,275 - $129,277	-24,392 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$4.7 - $7.24 $24,092 - $37,112	-5,126 Reduced 17.37%	24,392 $119,000
Q2 2021 Aug 16, 2021	BUY	$6.81 - $10.93 $87,597 - $140,592	12,863 Added 77.23%	29,518 $201,000
Q1 2021 May 18, 2021	SELL	$6.14 - $8.31 $1,565 - $2,119	-255 Reduced 1.51%	16,655 $118,000
Q4 2020 Feb 17, 2021	SELL	$4.58 - $7.14 $73,870 - $115,161	-16,129 Reduced 48.82%	16,910 $106,000
Q2 2020 Aug 17, 2020	BUY	$2.97 - $5.22 $98,125 - $172,463	33,039 New	33,039 $172,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.